Related Experiment Videos
[Clinics in prostate cancer]
1Department of Urology, Mie University School of Medicine, Tsu 514-8507.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 4, 2004
Summary
Prostate cancer and benign prostate hyperplasia are common age-dependent diseases in elderly men. Advances in screening, diagnostics, and treatments like LH-RH analogs have improved prostate cancer care.
Area of Science:
- Urology
- Oncology
- Geriatrics
Context:
- Age-dependent proliferative diseases of the prostate gland, including benign prostate hyperplasia and prostate cancer, are significant health concerns.
- Prostate cancer represents a major health issue, particularly affecting the elderly population.
Purpose:
- To summarize the pathogenesis, diagnosis, and treatment of prostate cancer.
- To highlight recent advancements in managing prostate cancer.
Summary:
- Prostate cancer diagnosis and treatment have seen significant improvements.
- Key advancements include Prostate-Specific Antigen (PSA) screening, transrectal ultrasonography, and novel anti-androgen therapies like Luteinizing Hormone-Releasing Hormone (LH-RH) analogs.
- These new treatments offer improved efficacy with fewer side effects.
Impact:
- Enhanced diagnostic capabilities and therapeutic options improve patient outcomes for prostate cancer.
- The review provides a comprehensive overview for clinicians and researchers in the field of prostate health.
- Advances contribute to better management strategies for age-related prostate conditions.